We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

BD Biosciences Releases BD FACSCanto™ II Flow Cytometry System

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BD Biosciences, a segment of BD (Becton, Dickinson and Company) has announced the U.S clearance and release of the BD FACSCanto™ II flow cytometry system for in vitro diagnostic (IVD) use.

This benchtop analyzer supports the six-color flow cytometry IVD application for routine HIV/AIDS monitoring using a one-tube test.

Health professionals regularly use flow cytometry to obtain CD4 test results to make important treatment decisions in HIV-infected patients, most notably when the disease has progressed to the point where initiation of antiretroviral treatment (ARV) would be beneficial.

The BD FACSCanto II system demonstrates BD Biosciences' continued commitment to the growing need for IVD products. The system is also CE-IVD marked and was released in Europe earlier this year.

The system provides automated sample loading with the BD FACS™ loader or the BD™ High Throughput Sampler option, enabling walk-away sample acquisition and freeing valuable time for laboratory personnel to focus on other tasks.

Its integrated fluidics cart holds all fluids necessary for routine operation and maintenance, facilitating automated system cleaning, startup, and shutdown routines to help laboratories focus on what's important - analysis and reporting of data.

"For more than 30 years, BD flow cytometers have paved the way for state-of-the-art cell analysis, becoming the method of choice for researchers and clinicians who measure and chart characteristics and properties of cells, particularly cells of the immune system," said Bill Rhodes, President, Cell Analysis.

"The design of the BD FACSCanto II system brings all of our expertise to bear, providing the latest tool to advance potentially lifesaving research and meet the complex needs of the 21st century clinical laboratory market."